Inhibitory effects of eugenol on putative nociceptive response in spinal cord preparation isolated from neonatal rats
Eugenol is contained in several plants including clove and is thought to exert an analgesic effect. It has been suggested that the slow ventral root potential induced by ipsilateral dorsal root stimulation in the isolated (typically lumbar) spinal cord of newborn rats reflects the nociceptive response, and this in vitro experimental model is useful to assess the actions of analgesics. To further elucidate neuronal mechanisms of eugenol-induced analgesia, we examined the effects of extracellularly applied eugenol on the nociceptive spinal reflex response. To evaluate the effects of eugenol on putative nociceptive responses, the ipsilateral fifth lumbar (L5) dorsal root was stimulated using a glass suction electrode, and the induced reflex responses were recorded from the L5 and twelfth thoracic (Th12) ventral roots in spinal cord preparations (Th10–L5) from newborn rats (postnatal day 0–3). We found that eugenol (0.25–1.0 mM) caused dose-dependent attenuation of the reflex response and also depressed spontaneous ventral root activity. We also found that the slow ventral root potential was further divided into two components: initial and late components. A lower concentration of eugenol selectively depressed the late component. The inhibitory effects by 1.0 mM eugenol were not reversed by 10 µM capsazepine (TRPV1 antagonist) or 40 µM HC-030031 (TRPA1 antagonist). The depressive effect of eugenol on the reflex response was also confirmed by optical recordings using voltage-sensitive dye. Our report provides additional evidence on the basic neuronal mechanisms of eugenol to support its clinical use as a potential analgesic treatment.
KeywordsEugenol Nociceptive response Slow ventral root potential Newborn rat In vitro
This work was partially supported by Grants-in-Aid for Scientific Research (KAKENHI: 25430012).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- Aoyama R, Okada Y, Yokota S, Yasui Y, Fukuda K, Shinozaki Y, Yoshida H, Nakamura M, Chiba K, Kato F, Toyama Y (2011) Spatiotemporal and anatomical analyses of P2X receptor-mediated neuronal and glial processing of sensory signals in the rat dorsal horn. Pain 152:2085–2097CrossRefPubMedGoogle Scholar
- Gavva NR, Tamir R, Qu Y, Klionsky L, Zhang TJ, Immke D, Wang J, Zhu D, Vanderah TW, Porreca F, Doherty EM, Norman MH, Wild KD, Bannon AW, Louis JC, Treanor JJ (2005) AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties. J Pharmacol Exp Ther 313:474–484CrossRefPubMedGoogle Scholar
- Hayakawa C, Inagaki K, Minoura Y, Onimaru H (2016) Effects of a quaternary lidocaine derivative, QX-314, on slow ventral root potentials in neonatal rats. Austin J Anesth Analg 4:1051Google Scholar
- Kotani S, Onimaru H (2017) Neuronal mechanisms of inhibitory effects of eugenol on respiratory neuron activity in the brainstem-spinal cord preparation. J Physiol Sci 67:S113Google Scholar